JDD Highlights

Next Steps in Derm: Interleukin-17 Inhibitors Therapeutic Cheat Sheet

By November 21, 2019April 12th, 2023No Comments
Biologics have revolutionized the treatment of psoriasis, and with new entries into the class, PASI90 and 100 have become attainable for many patients.
 Next Steps in Derm‘s  most recent installment of Therapeutic Cheat Sheet series covers everything you need to know to start and monitor your patients on IL-17 blocking therapies.
Get more from the JDD - Subscribe today!

You May Also Like

AcneDerm CommunityFeatured ArticlesJDD HighlightsJDD in the MediaThe Latest
May 21, 2025

JDD in the News: Upadacitinib’s Potential Cardiovascular Effects 

Upadacitinib may provide additional health benefits, including reducing the risk of major adverse cardiovascular events (MACE) and venous thromboembolism (VTE). That’s according to a May Journal of Drugs in Dermatology…
AcneDerm CommunityFeatured ArticlesJDD HighlightsJDD in the MediaThe Latest
February 14, 2025

JDD in the News: Micropeptide Addresses Aging, Inflammation

A recent Journal of Drugs in Dermatology study about a micropeptide with anti-aging and anti-inflammatory effects made news in Dermatology Times. The study, “Acetyl Dipeptide-31 Amide: A Novel Cosmetic Anti-Inflammatory…
AcneDerm CommunityFeatured ArticlesJDD HighlightsJDD in the MediaThe Latest
November 14, 2024

JDD in the News: Hyperhidrosis & Sensitive Skin Connection; Dermatitis from Poppers

By Allison Sit Dermatology Advisor and Physician’s Weekly each shared a HealthDay article about a JDD study on a possible relationship between hyperhidrosis and sensitive skin. The study, “Primary Hyperhidrosis…